Login
$EDIT
$1.96 +$0.09 (4.81%) After hours

$EDIT 8-K/A SEC Filings

Filed On Filing
19 Feb 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously reported on a Current Report on Form 8-K filed on February 8, 2021 (the “Prior Report”), on February 4, 2021, James C. Mullen was appointed as President and Chief Executive Officer of Editas Medicine, Inc. (the “Company”), ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support